Author: WeWorldMedia-admin

Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of RFA-AG-23-016 Transition to Aging Research for Predoctoral Students (F99/K00 – Clinical Trial Not Allowed)

Published: 21 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of RFA-AG-23-016 – Transition to Aging Research for Predoctoral Students (F99/K00 – Clinical Trial Not Allowed)

Notice Number:

NOT-AG-24-072

Key Dates

Release Date:

January 21, 2025

Estimated Publication Date of Notice of Funding Opportunity :

April 30, 2025

First Estimated Application Due Date:

September 17, 2025

Earliest Estimated Award Date:

June 17, 2026

Earliest Estimated Start Date:

June 17, 2026

Related Announcements

<div data-element-id="157273" data-element-has-label="true" data-element-required="true"

Click this link to continue reading the article on the source website.

Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimers Disease (AD) and AD-Related Dementias (ADRD)

Published: 21 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD)

This Notice of Special Interest (NOSI) encourages research on the use of digital technology for early detection and monitoring of cognitive and functional decline in persons with Alzheimer’s disease (AD) and AD-related dementias (ADRD). This NOSI is a reissue of NOT-AG-21-048.

Background

Early diagnosis and monitoring of AD/ADRD is an unmet need and a major goal in the Department of Health and Human Services’ National Plan to Address Alzheimer’s Disease. There is evidence that the functional, psychological, pathological, and physiological changes underlying AD/ADRD may emerge many years prior to the clinical manifestation of cognitive symptoms, prompting this call to identify earlier indicators of disease risk and subclinical disease burden.

Many current biomarkers for early detection of prodromal AD/ADRD (e.g., PET/MRI imaging)

Click this link to continue reading the article on the source website.

NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)

Published: 17 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute on Aging (NIA)

Funding Opportunity Title

NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)

Activity Code

F32 Postdoctoral Individual National Research Service Award

Announcement Type

Related Notices

August 31, 2022– Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198. August 5, 2022– Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.

Funding Opportunity Number (FON)

PAR-24-332

Companion Notice of Funding Opportunity

PAR-24-333 , F31

Click this link to continue reading the article on the source website.